Summary
There are conflicting data on the existence of significant first-pass metabolism of alcohol (ethanol) in the human stomach and its inhibition by histamine H2-receptor antagonists. Alcohol is predominantly metabolised in the liver by the microsomal alcohol oxidising system, alcohol dehydrogenase (ADH) and a catalase enzyme. Histochemical and kinetic studies have revealed several ADH isoenzymes in the gastric mucosa with different kinetic properties. After small oral doses of alcohol first-pass metabolism in the stomach occurs, as shown by reduced area under the plasma concentration-time curve (AUC) compared with intravenous or intraduodenal administration. The activity of gastric ADH is reduced in women, the elderly, Asian individuals, the fasting state, chronic alcoholism and after gastrectomy. The effect is only present with small (≤0.3 g/kg) alcohol doses and with a high alcohol concentration.
In a number of studies, cimetidine in therapeutic doses over 7 days produced a significant increase in the AUC and in the peak plasma concentration after administration of alcohol 0.15 and 0.30 g/kg. This was related to an inhibition of gastric ADH activity, as shown by in vitro studies. Ranitidine inhibited gastric ADH to a similar extent on a molar basis, but its effect on alcohol levels in vivo was less constant in various studies. Nizatidine also reduced gastric alcohol first-pass metabolism, but famotidine and roxatidine did not show this effect. In other studies, H2-receptor antagonists did not change AUC and peak alcohol concentration.
The controversy is not easy to resolve, since a number of the positive studies did not use a placebo-controlled, randomised, crossover design, while some of the negative studies did not exclude habitual alcohol consumers and included Oriental volunteers, although both groups have been shown to lack significant gastric ADH activity. In this case, when first-pass metabolism of alcohol does not exist, this by definition cannot be abolished by H2-antagonists. The inclusion of oral and intravenous dosage data of alcohol is mandatory to positively identify first-pass metabolism in any individuals.
The significance of the effect of H2-antagonists on blood alcohol concentrations is minor. It only occurs in young, male, nonalcoholic, non-Asian individuals, and alcohol must be given in a small (social) dose, in a high concentration, and after meals. An increase in alcohol levels in predisposed patients during treatment with some H2-antagonists cannot be excluded, although the likelihood is small. Furthermore, carefully designed studies are needed to clarify fully the significance of this interaction.
Similar content being viewed by others
References
Baraona E, Yokoyama A, Ishii H, Hernández-Munoz R, Takagi T, et al. Lack of alcohol dehydrogenase isoenzyme activities in the stomach of Japanese subjects. Life Sciences 49: 1929–1934, 1991
Beil W,Sewing KFr. Wirkungen des Histamin-H2-Rezeptor-antagonisten Roxatidinazetat auf die Magen-und Leber-Al-koholdehydrogenase und den Serumalkoholspiegel. Zeitschrift für Gastroenterologie, in press, 1994
Bosron WF, Li TK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology 6: 502–510, 1986
Caballeria J. First-pass metabolism of ethanol. Its role as a determinant of blood alcohol levels after drinking. Hepato-Gastroenterology 39: 62–66, 1992
Caballeria J, Baraona E, Deulofeu R, Hernández-Munoz R, Rodés J, et al. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity. Digestive Diseases and Sciences 36: 1673–1679, 1991
Caballeria J, Baraona E, Rodamilans M, Lieber CS. Effects of cimetidine on gastric alcohol dehydrogenase activity and blood ethanol levels. Gastroenterology 96: 388–392, 1989a
Caballeria J, Frezza M, Hernández-Munoz R, DiPadova C, Korsten MA, et al. Gastric origin of the first-pass metabolism of ethanol in humans: effect of gastrectomy. Gastroenterology 97: 1205–1209, 1989b
DiPadova C, Roine R, Frezza M, Gentry RT, Baraona E, et al. Effects of ranitidine on blood alcohol levels after ethanol ingestion. Journal of the American Medical Association 267: 83–86, 1992
DiPadova C, Worner TM, Julkunen RJK, Lieber CS. Effects of fasting and chronic ethanol consumption on the first-pass metabolism of ethanol. Gastroenterology 92: 1169–1173, 1987
Dobrilla G, dePretis G, Piazzi L, Chilovi F, Comberlato M, et al. Is ethanol metabolism affected by oral administration of cimetidine and ranitidine at therapeutic doses? Hepato-Gastroenterology 31: 35–37, 19
Eckey R, Agarwal DP, Seitz KH, Goedde HW. Effect of sex and age on low-Km alcohol dehydrogenase activity in human stomach mucosa. Abstract. Alcohol and Alcoholism 26: 240, 1991
Feely J, Wood AJJ. Effects of cimetidine on the elimination and action of ethanol. Journal of the American Medical Association 247: 2819–2821, 1982
Fiatrone JR, Bennett MK, Kelly P, James OFW. Ranitidine but not gastritis or female sex reduces the first pass metabolism of ethanol. Abstract. Gut 32: A594, 1991
Fraser AG, Hudson M, Sawyerr M, Smith MSH, Sercombe J, et al. Ranitidine has no effect on postbreakfast ethanol absorption. American Journal of Gastroenterology 88: 217–221, 1993
Fraser AG, Prewett EJ, Hudson M, Sawyerr AM, Rosalki SB, et al. The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption. Alimentary Pharmacology and Therapeutics 5: 263–282, 1991
Fraser AG, Sawyerr AM, Hudson M, Smith M, Rosalki S, et al. Ranitidine, cimetidine and famotidine have no effect on post-prandial absorption of ethanol 0.8 g/kg taken after an evening meal. Alimentary Pharmacology and Therapeutics 6: 693–700, 1992
Frezza M, DiPadova C, Pozzato G, Terpin M, Baraona E, et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. New England Journal of Medicine 322: 95–99, 1990
Gentry RT, Sharma R, Lim RT, Baraona E, DiPadova, et al. A new method to quantify first pass metabolism of alcohol: application to the effects of H2 blockers on alcohol bioavailability. Abstract. Gastroenterology 102: A811, 1992
Graham DY, Malaty HM, Evans DG, Evans Jr DJ, Klein PD, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 100: 1495–1501, 1991
Guram M, Holt S. Are ethanol H2 receptor antagonist (H2RA) interactions relevant? Abstract. Gastroenterology 100: A749, 1991
Hernández-Munoz R, Caballeria J, Baraona E, Uppal R, Greenstein R, et al. Human gastric alcohol dehydrogenase: its inhibition by H2-receptor antagonists, and its effect on the bioavailability of ethanol. Alcoholism, Clinical and Experimental Research 14:946–950, 1990
Holmes RS, Courtney YR, VandeBerg JL. Alcohol dehydrogenase isozymes in baboons: tissue distribution, catalytic properties, and variant phenotypes in liver, kidney, stomach and testis. Alcoholism, Clinical and Experimental Research 10: 623–630, 1986
Holt S. Alcohol and H2-receptor antagonists. G.I. Report 5:4,1990a
Holt S. Alcohol and H2-receptor antagonists: over the counter, under the table? American Journal of Gastroenterology 85: 516–517, 1990b
Holt S. Human gastric alcohol dehydrogenase: assessing its clinical significance. Moderne Medicine 40–41, 1993
Holtmann G, Knop D, Becker S, Singer MV. Beeinflusst die einmalige orale Einnahme von Ramotidin den Blutalkoholspiegel? Deutsche Medizinische Wochenschrift 112: 1619–1620, 1987
Holtzmann JL, Gebhard RL, Eckfeld JH, Mottonen LR, Finley DK, et al. The effect of several weeks of alcohol consumption on ethanol kinetics in normal men and women. Clinical Pharmacology and Therapeutics 38: 157, 1986
Johnson KE, Fenzl E, Hein B. Einfluss von Cimetidin auf den Abbau und die Wirkung des Alkohols. Arzneimittel-Forschung 34: 734, 1984
Julia P, Farrés J, Parés X. Characterization of three isoenzymes of rat alcohol dehydrogenase: tissue distribution and physical and enzymatic properties. European Journal of Biochemistry 162:179–189, 1987
Julkunen RJK, DiPadova C, Lieber CS. First pass metabolism of ethanol: a gastrointestinal barrier against the systemic toxicity of ethanol. Life Sciences 37: 567–573, 1985
Kleine M, Ertl D. Comparative trial in volunteers to investigate ethanol (ETOH) ranitidine (R) interactions. Abstract. Gastroenterology 102: A98, 1992
Krebs HA, Perkins JR. The physiological role of liver alcohol dehydrogenase. Biochemical Journal 118: 635–644, 1970
Levitt MD. Review article: lack of clinical significance of the interaction between H2-receptor antagonists and ethanol. Alimentary Pharmacology and Therapeutics 7: 131–138, 1993
Lieber CS. Alcohol and the liver: metabolism of ethanol, metabolic effects and pathogenesis of injury. Acta Medica Scandinavica 705: 1155 1986
Lieber CS, DeCarli LM. Hepatic microsomal ethanol oxidizing system. In vitro characteristics and adaptive properties in vivo. Journal of Biological Chemistry 245: 2505–2512, 1970
Messiha FS, Hughes MJ. Liver alcohol and aldehyde dehydrogenase: inhibition and potentiation by histamine agonists and antagonists. Clinical and Experimental Pharmacology and Physiology 6: 281–292, 1979
Mezey E, Sharma S, Rennie L, Potter JJ. Sex differences in gastric alcohol dehydrogenase activity in Sprague-Dawley rats. Gastroenterology 103: 1804–1810, 1992
Moreno A, Parés X. Purification and characterization of a new alcohol dehydrogenase from human stomach. Journal of Biological Chemistry 266: 1228–1233, 1991
Palmer RH. Cimetidine and alcohol absorption. Gastroenterology 97: 1067–1068, 1989
Palmer RH, Frank WO, Nambi P, Wetherington JD, Fox MJ, et al. Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol. American Journal of Gastroenterology 86: 1749–1755, 1991
Puurunen J, Pelkonen O. Cimetidine inhibits microsomal drug metabolism in the rat. European Journal of Pharmacology 55: 335, 1979
Raufman JP, Notar-Francesco V, Raffaniello RD, Straus EW. Histamine-2 receptor antagonists do not alter serum ethanol levels in fed, nonalcoholic men. Annals of Internal Medicine 118:488–494, 1993
Roine R, DiPadova C, Frezza M, Hernández-Munoz R, Baraona E, et al. Effects of omeprazole, cimetidine and ranitidine on blood ethanol concentrations. Abstract. Gastroenterology 98: Al 14,1990
Roine R, Gentry RT, Lim RT, Baraona E, Lieber CS. Effect of concentration of ingested ethanol on blood alcohol levels. Alcoholism, Clinical and Experimental Research 15: 734–738, 1991
Salmela KS, Roine R, Koivisto T, Höök-Nikanne J, Kosunen TU, et al. Characteristics of Helicobacter pylori alcohol dehydrogenase. Gastroenterology 105: 325–330, 1993
Seitz HK, Egerer G, Oertel U, Xu Y, Simanowski UA, et al. Biochemical and immunhistological studies on alcohol dehydrogenase in the human stomach: effect of age, sex, alcoholism and cimetidine. Abstract. Gastroenterology 98: A629, 1990
Seitz HK, Simanowski UA, Egerer G, Waldherr R, Oertl U. Human gastric alcohol dehydrogenase: in vitro characteristics and effect of cimetidine. Digestion 51: 80–85, 1992
Seitz HK, Veith S, Czygan P, Bösche J, Simon B, et al. In vivo interactions between H2-receptor antagonists and ethanol metabolism in man and in rats. Hepatology 4: 1231–1234, 1984
Shinn AF. Clinical relevance of cimetidine drug interactions. Drug Safety 7: 245–267, 1992
Somogyi A, Gugler R. Drug interactions with cimetidine. Clinical Pharmacokinetics 7: 23–42, 1982
Tanaka E, Nakamura K. Effects of H2-receptor antagonists on ethanol metabolism in Japanese volunteers. British Journal of Clinical Pharmacology 26: 96–99, 1988
Vasudeva R, Verhulst S, Colliver J. Alcohol and smoking as determinants of dyspeptic symptoms. American Journal of Gastroenterology 84: 1172–1176,1989
Wagner JG. Lack of first-pass metabolism of ethanol at the blood concentrations in the social drinking range. Life Sciences 39:407–414, 1986
Webster LK, Jones DB, Smallwood RA. Influence of cimetidine and ranitidine on ethanol pharmacokinetics. New Zealand Journal of Medicine 15: 359–360, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gugler, R. H2-Antagonists and Alcohol. Drug-Safety 10, 271–280 (1994). https://doi.org/10.2165/00002018-199410040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199410040-00001